Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells-Reference-Cited by-同舟云学术

Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells

Published:2007-11 Issue:2 Volume:76 Page:140-149
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Ma Ke,Xu Wei,Shao Xianan,YanYue ,Hu Linkun,Xu Huanbin,Yuan Zhigang,Zheng Xiujuan,Xiong Sidong

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference37 articles.

1. RANTES: a versatile and controversial chemokine;Appay;Trends. Immunol.,2001

2. Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system;Ara;Immunology,2001

3. DNA-based immunotherapy: potential for treatment of chronic viral hepatitis?;Beckebaum;Rev. Med. Virol.,2002

4. Scavenger receptor-specific allergen delivery elicits IFN-gamma-dominated immunity and directs established TH2-dominated responses to a nonallergic phenotype;Bhatia;J. Allergy. Clin. Immunol.,2002

5. Overexpression of RANTES using a recombinant adenovirus vector induces the tissue-directed recruitment of monocytes to the lung;Braciak;J. Immunol.,1996

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Osteoid cell-derived chemokines drive bone-metastatic prostate cancer;Frontiers in Oncology;2023-03-21

2. Polysaccharides of Plantago asiatica enhance antitumor activity via regulating macrophages to M1-like phenotype;Biomedicine & Pharmacotherapy;2023-03

3. Lymphocyte-Related Immunomodulatory Therapy with Siponimod (BAF-312) Improves Outcomes in Mice with Acute Intracerebral Hemorrhage;Aging and disease;2022

4. Elevated level of cerebrospinal fluid and systemic chemokine CCL5 is a predictive biomarker of clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH);Cytokine;2020-09

5. Functional roles of CCL5/RANTES in liver disease;Liver Research;2020-03